Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Risk-Based Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:

Closed

IRB Study ID:

100904

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

Lead Investigator

Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...